The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment

Neeraj Dhaun, Vanessa Melville, William G. Kramer, Fiona Stavros, Terrance Coyne, Suzanne K. Swan, Jane Goddard, David J. Webb

British Journal of Clinical Pharmacology · 2007 · 16 citations · 9 references

DOIFull text

Open access

Abstract

After a single 100-mg oral dose of sitaxsentan there were no differences in its pharmacokinetics among subjects with normal or impaired renal function.

References

9